Work

Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.

Year: 1995

Type: article

Source: PubMed

Authors: S Langouët, B Coles, F Morel, L Becquemont, P Beaune, F P Guengerich, B Ketterer, A Guillouzo

Institution: Inserm

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: ENZYMIC ACTIVATION OF CHEMICAL CARCINOGENS

OpenAlex ID: W1545611675

FWCI: 7.71

Cites:

Cited by: 151

Related to: 10